Related Experiment Videos
[Primary retroperitoneal pure choriocarcinoma]
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|December 1, 1995
Summary
A rare case of primary retroperitoneal pure choriocarcinoma was successfully treated with intensive chemotherapy and surgical resection. This aggressive multimodal approach offers a promising strategy for managing this challenging malignancy.
Area of Science:
- Oncology
- Medical Diagnostics
- Surgical Oncology
Background:
- Primary retroperitoneal pure choriocarcinoma is an extremely rare germ cell tumor.
- Diagnosis often relies on elevated human chorionic gonadotropin (hCG) levels and imaging.
- This case highlights a unique presentation and successful management strategy.
Observation:
- A 30-year-old male presented with supraclavicular lymphadenopathy and multiple lung/mediastinal tumors.
- Abdominal CT revealed retroperitoneal masses; testicular examination was normal.
- Biopsy confirmed pure choriocarcinoma with elevated beta-hCG.
Findings:
- The patient received etoposide, ifosfamide, and cisplatin (VIP) followed by bleomycin, etoposide, and cisplatin (BEP) chemotherapy.
- Partial response to chemotherapy necessitated surgical removal of residual masses.
- Histopathology of resected masses showed necrotic fibrous tissue, indicating successful treatment.
Implications:
- Intense chemotherapy regimens, such as VIP, are crucial for treating primary retroperitoneal pure choriocarcinoma.
- Aggressive surgical resection of residual masses post-chemotherapy is vital for achieving disease-free survival.
- This case underscores the importance of a multidisciplinary approach in managing rare germ cell tumors.